Long-Term Extension Study of MP-214 in Patients With Schizophrenia
Phase of Trial: Phase II/III
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Cariprazine (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 05 Apr 2017 Status changed from active, no longer recruiting to completed.
- 12 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 06 Oct 2016 New trial record